HK1248756A1 - 乳酸菌及其用於治療乳腺炎的用途 - Google Patents

乳酸菌及其用於治療乳腺炎的用途

Info

Publication number
HK1248756A1
HK1248756A1 HK18108243.8A HK18108243A HK1248756A1 HK 1248756 A1 HK1248756 A1 HK 1248756A1 HK 18108243 A HK18108243 A HK 18108243A HK 1248756 A1 HK1248756 A1 HK 1248756A1
Authority
HK
Hong Kong
Prior art keywords
mastitis
treatment
lactic acid
acid bacteria
bacteria
Prior art date
Application number
HK18108243.8A
Other languages
English (en)
Inventor
Bo Möllstam
Eamonn Connolly
Original Assignee
Biogaia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogaia Ab filed Critical Biogaia Ab
Publication of HK1248756A1 publication Critical patent/HK1248756A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0041—Mammary glands, e.g. breasts, udder; Intramammary administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Dermatology (AREA)
  • Reproductive Health (AREA)
  • Communicable Diseases (AREA)
  • Endocrinology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Oncology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
HK18108243.8A 2015-01-16 2018-06-27 乳酸菌及其用於治療乳腺炎的用途 HK1248756A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562104164P 2015-01-16 2015-01-16
PCT/EP2016/050699 WO2016113365A1 (en) 2015-01-16 2016-01-14 Lactic acid bacteria and their use for the treatment of mastitis

Publications (1)

Publication Number Publication Date
HK1248756A1 true HK1248756A1 (zh) 2018-10-19

Family

ID=56405271

Family Applications (1)

Application Number Title Priority Date Filing Date
HK18108243.8A HK1248756A1 (zh) 2015-01-16 2018-06-27 乳酸菌及其用於治療乳腺炎的用途

Country Status (12)

Country Link
US (2) US20180273895A1 (zh)
EP (1) EP3244904A1 (zh)
JP (1) JP2018504902A (zh)
KR (1) KR20170103804A (zh)
CN (1) CN107532137A (zh)
AU (1) AU2016208009A1 (zh)
BR (1) BR112017014225A2 (zh)
CA (1) CA2972967A1 (zh)
CL (1) CL2017001818A1 (zh)
HK (1) HK1248756A1 (zh)
MX (1) MX2017007969A (zh)
WO (1) WO2016113365A1 (zh)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT201700062260A1 (it) * 2017-06-07 2018-12-07 Proge Farm Srl Associazione e composizioni topiche cutanee comprendenti lattobacilli e ossidi metallici e/o semimetallici
AU2019403248A1 (en) * 2018-12-19 2021-07-15 Healthy Cow Corporation Ready-to-use probiotic compositions and uses thereof
WO2021058688A1 (en) * 2019-09-26 2021-04-01 Precisionbiotics Group Limited Lactobacillus reuteri
CA3186421A1 (en) * 2020-06-30 2022-01-06 Biogaia Ab Probiotic composition for topical use

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7955834B2 (en) * 2004-06-03 2011-06-07 Biogaia Ab Method for improved breast milk feeding to reduce the risk of allergy
EP1997499A1 (en) * 2007-05-31 2008-12-03 Puleva Biotech, S.A. Mammalian milk microorganisms, compositions containing them and their use for the treatment of mastitis
US20130022586A1 (en) * 2011-07-21 2013-01-24 James Versalovic Production and use of bacterial histamine
IN2014DN05881A (zh) * 2011-12-30 2015-05-22 Abbott Lab

Also Published As

Publication number Publication date
KR20170103804A (ko) 2017-09-13
WO2016113365A1 (en) 2016-07-21
CA2972967A1 (en) 2016-07-21
CN107532137A (zh) 2018-01-02
JP2018504902A (ja) 2018-02-22
US20180273895A1 (en) 2018-09-27
EP3244904A1 (en) 2017-11-22
AU2016208009A1 (en) 2017-07-20
MX2017007969A (es) 2018-04-10
US20200318061A1 (en) 2020-10-08
BR112017014225A2 (pt) 2018-03-06
CL2017001818A1 (es) 2018-03-02

Similar Documents

Publication Publication Date Title
SG10201913050RA (en) Novel lactic acid bacteria and use thereof
IL271085A (en) Bacteria to treat disorders
EP3483259A4 (en) NOVEL MILK ACID BACTERIA AND USE THEREOF
SG10201913043TA (en) Novel lactic acid bacteria and use thereof
HK1223628A1 (zh) β- 新的 -酮- β-烷基膽烷酸衍生物在製備奧貝膽酸以及其在醫藥領域的用途
HK1245641A1 (zh) 次氯酸製劑及治療皮膚病的方法
IL246942A0 (en) micro rnas and compounds containing them for the treatment and diagnosis of medical conditions related to serotonin, adrenaline, noradrenaline, glutamate and corticotropin-releasing hormone
EP3715449C0 (en) NEW LACTIC BACTERIA AND THEIR USE
SG11202104408UA (en) Novel lactic acid bacteria and use thereof
PL3431580T3 (pl) Bakterie kwasu mlekowego do wytwarzania kiszonki i dodatek do wytwarzania kiszonki
HK1248756A1 (zh) 乳酸菌及其用於治療乳腺炎的用途
HUE062784T2 (hu) Indolinon vegyületek és alkalmazásuk fibrotikus betegségek kezelésében
SG11201610413RA (en) Lactic acid bacteria suppressing purine absorption and use thereof
HK1243951A1 (zh) 抗微生物組合和其在治療微生物感染中的用途
IL269546A (en) Lactic acid bacteria, methods and uses thereof
PT3285787T (pt) Tratamento de infeções bacterianas em aquicultura
SG11201702816QA (en) Lactic acid bacteria having purine uptake ability and use thereof
SG11201701577WA (en) Lactic acid bacteria-containing composition
EP3578637A4 (en) NEW LACTIC BACTERIA AND THEIR USE
ZA201802201B (en) Novel formulation and treatment methods
IL253418A0 (en) Nisin-based compounds and their use in the treatment of bacterial infections
ZA201807354B (en) Disinfecting composition comprising tartaric acid and lactic acid
ZA201801788B (en) Lysobactin for use in the treatment of bovine mastitis
HUP1400338A2 (hu) Probiotikus baktériumok alkalmazása külsõ hallójárat gyulladás kezelésére, továbbá azokat tartalmazó készítmény
AU2015900093A0 (en) Improved probiotic and/or biocide for treatment of plants & fish